GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arena Pharmaceuticals Inc (FRA:RN3N) » Definitions » E10

Arena Pharmaceuticals (FRA:RN3N) E10 : €-2.70 (As of Dec. 2021)


View and export this data going back to 2000. Start your Free Trial

What is Arena Pharmaceuticals E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Arena Pharmaceuticals's adjusted earnings per share data for the three months ended in Dec. 2021 was €-2.248. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-2.70 for the trailing ten years ended in Dec. 2021.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-05-21), Arena Pharmaceuticals's current stock price is €90.50. Arena Pharmaceuticals's E10 for the quarter that ended in Dec. 2021 was €-2.70. Arena Pharmaceuticals's Shiller PE Ratio of today is .


Arena Pharmaceuticals E10 Historical Data

The historical data trend for Arena Pharmaceuticals's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arena Pharmaceuticals E10 Chart

Arena Pharmaceuticals Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -8.20 -5.33 -3.10 -2.35 -2.70

Arena Pharmaceuticals Quarterly Data
Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.35 -2.28 -2.46 -2.54 -2.70

Competitive Comparison of Arena Pharmaceuticals's E10

For the Biotechnology subindustry, Arena Pharmaceuticals's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arena Pharmaceuticals's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arena Pharmaceuticals's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Arena Pharmaceuticals's Shiller PE Ratio falls into.



Arena Pharmaceuticals E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Arena Pharmaceuticals's adjusted earnings per share data for the three months ended in Dec. 2021 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2021 (Change)*Current CPI (Dec. 2021)
=-2.248/117.6295*117.6295
=-2.248

Current CPI (Dec. 2021) = 117.6295.

Arena Pharmaceuticals Quarterly Data

per share eps CPI Adj_EPS
201203 -1.363 96.783 -1.657
201206 -0.956 96.819 -1.161
201209 -0.543 97.633 -0.654
201212 -0.762 96.871 -0.925
201303 -0.695 98.209 -0.832
201306 1.364 98.518 1.629
201309 -0.598 98.790 -0.712
201312 -0.803 98.326 -0.961
201403 -0.868 99.695 -1.024
201406 0.221 100.560 0.259
201409 -0.388 100.428 -0.454
201412 -1.216 99.070 -1.444
201503 -0.924 99.621 -1.091
201506 -0.980 100.684 -1.145
201509 -0.980 100.392 -1.148
201512 -1.193 99.792 -1.406
201603 -0.808 100.470 -0.946
201606 -0.997 101.688 -1.153
201609 -0.454 101.861 -0.524
201612 1.517 101.863 1.752
201703 -0.841 102.862 -0.962
201706 -0.685 103.349 -0.780
201709 -0.722 104.136 -0.816
201712 -0.296 104.011 -0.335
201803 -0.649 105.290 -0.725
201806 -0.556 106.317 -0.615
201809 -0.600 106.507 -0.663
201812 1.187 105.998 1.317
201903 10.709 107.251 11.745
201906 -1.097 108.070 -1.194
201909 -1.326 108.329 -1.440
201912 -1.584 108.420 -1.719
202003 -1.810 108.902 -1.955
202006 -1.430 108.767 -1.547
202009 -1.435 109.815 -1.537
202012 -1.726 109.897 -1.847
202103 -1.663 111.754 -1.750
202106 -1.992 114.631 -2.044
202109 -2.729 115.734 -2.774
202112 -2.248 117.630 -2.248

Add all the adjusted EPS together and divide 10 will get our e10.


Arena Pharmaceuticals  (FRA:RN3N) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Arena Pharmaceuticals E10 Related Terms

Thank you for viewing the detailed overview of Arena Pharmaceuticals's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Arena Pharmaceuticals (FRA:RN3N) Business Description

Traded in Other Exchanges
N/A
Address
136 Heber Avenue, Suite 204, Park City, UT, USA, 84060
Arena Pharmaceuticals is a biotechnology company targeting G-protein-coupled receptors. The company has one internally discovered drug, lorcaserin, which has been approved and is marketed in the U.S. and South Korea to target weight management. It is commercialized under the brand name Belviq. The company is collaborating with Eisai to market Belviq in other countries. It has a presence in Europe through its Swiss subsidiary, Arena GmbH. The company's pipeline contains drugs targeting autoimmune diseases, vascular diseases, thrombotic diseases, dementia-associated psychosis, nervous system issues, and pain.

Arena Pharmaceuticals (FRA:RN3N) Headlines

No Headlines